Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report

References

• Casadonte PP. Transfer from methadone to buprenorphine. 2013.
   Google Scholar
• Hanon S, Seewald RM, Yang F, Schweitzer P, Rosman J. Ventricular arrhythmias in patients treated with methadone for opioid dependence. J Interv Card Electrophysiol. 2010;28:19–22.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). Substance abuse treatment: Group therapy. Rockville, MD: Substance Abuse and Mental Health Services Administration;2005.
   Google Scholar
• Breen CL, Harris SJ, Lintzeris N. Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions. Drug Alcohol Depen. 2003;71:49–55.
   PubMed Web of Science ®Google Scholar
• Johnson S, Martin PR. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy. Am J Drug Alcohol Abuse. 2018;44:310–316.
   PubMed Web of Science ®Google Scholar
• Law FD, Bailey JE, Allen DS, et al. The feasibility of abrupt methadone-buprenorphine transfer in British opiate addicts in an outpatient setting. Addict Biol. 1997;2:191–200.
   PubMed Web of Science ®Google Scholar
• Levin FR, Fischman MW, Connerney I, Foltin RW. A protocol to switch high-dose, methadone-maintained subjects to buprenorphine. Am J Addict. 1997;6:105–116.
   PubMed Web of Science ®Google Scholar
• Mannelli P, Peindl KS, Lee T, Bhatia KS, Lt W. Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives. Curr Drug Abuse Rev. 2012;5:52–63.
   PubMedGoogle Scholar
• Oretti R. A retrospective evaluation of inpatient transfer from high-dose methadone to buprenorphine substitution therapy. J Subst Abuse Treat. 2015;57:102–105.
   PubMed Web of Science ®Google Scholar
• Salsitz EA, Holden CC, Tross S, Nugent A. Transitioning stable methadone maintenance patients to buprenorphine maintenance. J Addict Med. 2010;4:88–92.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). Medications for Opioid Use Disorder. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2018.
   Google Scholar
• Rosado J, Walsh SL, Bigelow GE, Strain EC. Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone. Drug Alcohol Depen. 2007;90:261–269.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2004.
   Google Scholar
• Bammer G, Battisson L, Ward J, Wilson S. The impact on retention of expansion of an Australian public methadone program. Drug Alcohol Depen. 2000;58:173–180.
   PubMed Web of Science ®Google Scholar
• Calsyn DA, Malcy JA, Saxon AJ. Slow tapering from methadone maintenance in a program encouraging indefinite maintenance. J Subst Abuse Treat. 2006;30:159–163.
   PubMed Web of Science ®Google Scholar
• Cushman P. Jr., Ten years of methadone maintenance treatment: some clinical observations. Am J Drug Alcohol Abuse. 1977;4:543–553.
   PubMed Web of Science ®Google Scholar
• Dennis M, Scott CK. Managing addiction as a chronic condition. Addict Sci Clin Pract. 2007;4:45–55.
   PubMedGoogle Scholar
• Gearing FR. Methadone maintenance treatment. Five years later-where are they now? Am J Public Health. 1974;64(Suppl 12):44–50.
   PubMedGoogle Scholar
• Termorshuizen F, Krol A, Prins M, et al. Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users. Drug Alcohol Depen. 2005;79:231–240.
   PubMed Web of Science ®Google Scholar
• Glasper A, Reed LJ, Wet CJ, Gossop M, Bearn J. Induction of patients with moderately severe methadone dependence onto buprenorphine. Addict Biol. 2005;10:149–155.
   PubMed Web of Science ®Google Scholar
• Urban V, Sullivan R. Buprenorphine rescue from naltrexone-induced opioid withdrawal during relatively rapid detoxification from high-dose methadone: a novel approach. Psychiatry. 2008;5:56–58.
   PubMedGoogle Scholar
• Collins ED, Kleber HD, Whittington RA, Heitler NE. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial. JAMA. 2005;294(8):903–913.
   PubMed Web of Science ®Google Scholar
• O'Connor PG, Kosten TR. Rapid and ultrarapid opioid detoxification techniques. JAMA. 1998;279:229–234.
   PubMed Web of Science ®Google Scholar
• Ehret GB, Desmeules JA, Broers B. Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology. Expert Opin Drug Saf. 2007;6:289–303.
   PubMed Web of Science ®Google Scholar
• Fanoe S, Hvidt C, Ege P, Jensen GB. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen. Heart. 2007;93:1051–1055.
   PubMed Web of Science ®Google Scholar
• Fishman MJ, Wu LT, Woody GE. Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence. Am J Psychiatry. 2011;168:675–679.
   PubMed Web of Science ®Google Scholar
• Gupta A, Lawrence AT, Krishnan K, Kavinsky CJ, Trohman RG. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J. 2007;153:891–899.
   PubMed Web of Science ®Google Scholar
• Johnson RE, Strain EC, Amass L. Buprenorphine: how to use it right. Drug Alcohol Depen. 2003;70:S59–S77.
   PubMed Web of Science ®Google Scholar
• Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN. Impact of methadone treatment on cardiac repolarization and conduction in opioid users. Am J Cardiol. 2005;95:915–918.
   PubMed Web of Science ®Google Scholar
• Mittal L. Buprenorphine for the treatment of opioid dependence in pregnancy. J Perinat Neonatal Nurs. 2014;28:178–184.
   PubMed Web of Science ®Google Scholar
• Wedam EF, Bigelow GE, Johnson RE, Nuzzo PA, Haigney MC. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Arch Intern Med. 2007;167:2469–2475.
   PubMed Web of Science ®Google Scholar
• Whitley SD, Kunins HV, Arnsten JH, Gourevitch MN. Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services. J Subst Abuse Treat. 2007;33:85–90.
   PubMed Web of Science ®Google Scholar
• Winstock AR, Lintzeris N, Lea T. Why do patients report transferring between methadone and buprenorphine? Drug Alcohol Rev. 2009;28:686–687.
   PubMed Web of Science ®Google Scholar
• Suzuki J, DeVido J, Kalra I, et al. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series. Am J Addict. 2015;24:10–14.
   PubMed Web of Science ®Google Scholar
• Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs. 2003;35:253–259.
   PubMed Web of Science ®Google Scholar
• Hassanian-Moghaddam H, Afzali S, Pooya A. Withdrawal syndrome caused by naltrexone in opioid abusers. Hum Exp Toxicol. 2014;33:561–567.
   PubMed Web of Science ®Google Scholar
• Naji L, Dennis BB, Bawor M, et al. The association between age of onset of opioid use and comorbidity among opioid dependent patients receiving methadone maintenance therapy. Addict Sci Clin Pract. 2017;12:9.
   PubMed Web of Science ®Google Scholar
• Roncero C, Barral C, Rodriguez-Cintas L, et al. Psychiatric comorbidities in opioid-dependent patients undergoing a replacement therapy programme in Spain: the PROTEUS study. Psychiatry Res. 2016;243:174–181.
   PubMed Web of Science ®Google Scholar
• Manhapra A, Quinones L, Rosenheck R. Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration. Drug Alcohol Depend. 2016;160:82–89.
   PubMed Web of Science ®Google Scholar